Form 8-K - Current report:
SEC Accession No. 0001193125-16-787455
Filing Date
2016-12-07
Accepted
2016-12-07 16:23:02
Documents
8
Period of Report
2016-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d274702d8k.htm 8-K 20572
2 EX-1.1 d274702dex11.htm EX-1.1 165751
3 EX-5.1 d274702dex51.htm EX-5.1 6541
4 EX-99.1 d274702dex991.htm EX-99.1 9731
5 EX-99.2 d274702dex992.htm EX-99.2 9767
6 GRAPHIC g274702g02w66.jpg GRAPHIC 3521
7 GRAPHIC g274702g29n83.jpg GRAPHIC 3423
8 GRAPHIC g274702g57f06.jpg GRAPHIC 2378
  Complete submission text file 0001193125-16-787455.txt   226877
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 162039294
SIC: 2836 Biological Products, (No Diagnostic Substances)